Advancing Revolutionary Therapies podcast

CMC Pitfalls: From Benchtop to IND

0:00
12:38
Reculer de 15 secondes
Avancer de 15 secondes

Listen as members of Veristat’s regulatory team outline the fundamentals— and the pitfalls— as you determine your readiness to file an Investigational New Drug (IND) from a manufacturing perspective.

D'autres épisodes de "Advancing Revolutionary Therapies"